Initial Management of Allergic Rhinitis in the Community—Could It Be Expanded?

Year 2021, Volume: 4 Issue: 2, 62 - 67, 30.08.2021

Andreena Nae Michael Patrick Colreavy

https://izlik.org/JA38WH48SJ

Abstract

Objectives: To analyze the initial investigation and management of allergic rhinitis (AR) patients in general practice and determine if it could be expanded further.

Methods: Clinical letters of patients with a diagnosis of AR seen in our outpatient’s department for the past 5 years were retrospectively reviewed. We have confirmed the diagnosis when possible, with allergy tests.

Results: From 555 patients included in our study, 90.6% were referred by their general practitioner (GP). Male to female ratio was 1.7. Almost half of the patients presented with nasal congestion had typical AR symptoms. A positive personal history of atopy was present in 19% of cases. Only 4% of GPs performed nasal examination on their patients. One hundred and five patients (19%) were prescribed nasal sprays, but they neither received instructions on the technique nor were told to use them long term. Twelve percent of the cases had allergy testing done prior to our clinic assessment, which confirmed allergen sensitization in 82% of these cases.

Conclusions: More efficient triaging and initial management of GP and otolaryngology referrals for rhinitis could result in fewer patients needing hospital management. We propose an instruction manual for GP suggesting initial appropriate and consistent topical therapy for at least 3 months, particularly in patients with a positive personal or family history of atopy, who have also been instructed in allergy avoidance. Those who fail should have allergy testing
done or an alternative diagnosis considered.

Keywords

allergic rhinitis , atopy , nasal spray , paediatric , skin allergy testing.

References

• Passali D, Cingi C, Staffa P, Passali F, Muluk NB, Bellussi ML. The international study of the allergic rhinitis survey: Outcomes from 4 geographical regions. Asia Pac Allergy. 2018;8(1):e7.
• Pawankar R, Holgate ST, Canonica GW, Lockey RT, Blaiss MS. WAO white book on allergy update. World Allergy Organiz. 2013;8:11-19.
• Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(Suppl. 5):S147-S334.
• Lang K, Allen-Ramey F, Huang H, Rock M, Kaufman E, Dykewicz MS. Health care resource use and associated costs among patients with seasonal versus perennial allergic rhinitis. Allergy Asthma Proc. 2016;37(5):103-111.
• Belhassen M, Demoly P, Bloch-Morot E, de Pouvourville G, Ginoux M. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy. 2017;72(6):948-958.
• Pols DHJ, Wartna JB, Moed H, van Alphen EI, Bohnen AM, Bindels PJE. Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: A systematic review scand. J Prim Health Care. 2016;34(2):143-150.
• Ryan D, van Weel C, Bousquet J, Toskala E, Ahlstedt A, Palkonen S. Primary care: The cornerstone of diagnosis of allergic rhinitis. Allergy. 2008;63(8):981- 989.
• Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-476.
• Bousquet J, Bodez T, Gehano P, et al. Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int Arch Allergy Immunol. 2009;150(1):75-82.
• Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: A longitudinal study. J Allergy Clin Immunol. 2007;120(4):863-869.
• Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: A longitudinal population-based study. Lancet. 2008;372(9643):1049-1057.
• Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J. 2009;18(4):300-305.
• Pols DHL, Nielen MMJ, Bohnen AM, Korevaar JC, Bindels PJE. Atopic children and use of prescribed medication: A comprehensive study in general practice. PLoS One. 2017;12(8):e0182664.
• Ryan D, Grant-Casey J, Scadding G, Pereira S, Pinnock H, Sheikh A. Management of allergic rhinitis in UK primary care: Baseline audit. Prim Care Respir J. 2005;14(4):204-209.
• Price DB, Scadding G, Bachert C, et al. UK prescribing practices as proxy markers of unmet need in allergic rhinitis: A retrospective observational study. NPJ Prim Care Respir Med. 2016;26:16033.
• Available at https://www.asthma.ie/sites/default/files/files/document_bank/2013/Aug/Allergic%20Rhinitis%20Low%20Res%20final.pdf. Accessed date September 2020.
• Duggan EM, Sturley J, Fitzgerald AP, Perry IJ, O’B Hourihane J. The 2002-2007 trends of prevalence of asthma, allergic rhinitis and eczema in Irish school children. Pediatr Allergy Immunol. 2012;23(5):464-471.
• Nae A, Hinchion K, Keogh IJ. A fifteen-year review of skin allergy testing in Irish patients with symptomatic rhinitis. World J Otorhinolaryngol Head Neck Surg. 2020. DOI: 10.1016/j.wjorl.2020.10.001.
• Kulig M, Klettke U, Wahn V, et al. Development of seasonal allergic rhinitis during the first 7 years of life. Asthma Rhinitis Other Respir Dise. 2000;106(5):832-839.
• Chen RF, Huang HC, Ou CY, et al. MicroRNA-21 expression in neonatal blood associated with antenatal immunoglobulin E production and development of allergic rhinitis. Clin Exp Allergy. 2010;40(10):1482-1490.
• Alm B, Goksör E, Thengilsdottir H, et al. Early protective and risk factors for allergic rhinitis at age 41/2 yr. Pediatr Allergy Immunol. 2011;22(4):398-404.
• Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy. 2007;38(1):19-42.
• Maurer M, Zuberbier T. Undertreatment of rhinitis symptoms in Europe: Findings from a cross-sectional questionnaire survey. Allergy. 2007;62(9):1057-1063.
• Bousquet PJ, Demoly P, Devillier P, Mesbah K, Bousquet J. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol. 2013;160(4):393-400.
• Laforest L, Bousquet J, Pietri G, et al. Quality of life during pollen season in patients with seasonal allergic rhinitis with or without asthma. Int Arch Allergy Immunol. 2005;136(3):281-286.
• Kuehl BL, Abdulnour S, O’Dell M, Kyle TK. Understanding the role of the healthcare professional in patient self-management of allergic rhinitis. SAGE Open Med. 2015;3:205031211559582-2050312115595822.
• Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006;100(2):354-362.
• Yang L, Hur K, Koempel J, Ference EH. Epistaxis health disparities in the United States pediatric population. Int J Pediatr Otorhinolaryngol. 2018;114:20-25.
• Neary E, Hourihane JO. Specific allergen immunotherapy use in 2012: An Irish paediatric surveillance unit (IPSU) study. Ir Med J. 2013;106(9):283-284.
• Topal E, Bakirtas A, Yılmaz O, et al. Predictive factors to differentiate between allergic and nonallergic rhinitis in children. Int Forum Allergy Rhinol. 2014;4(6):447-452.